Bluejay Diagnostics, Inc.BJDX

$4.46+0.02 (+0.45%)
NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap
$2M
Micro-cap
-100%
2021 — today
10-Year Price
-100%
2021 — today
52-Week Range
$1.67$14.00
Current $4.46· 23%

Bluejay Diagnostics, Inc. functions as a company specializing in medical diagnostic solutions. A key offering is their Symphony platform, an advanced technological system. This platform is composed of the Symphony analyzer, which skillfully orchestrates the processing of whole blood, the isolation of biomarkers, and the preparation of immunoassays using non-contact centrifugal force. It also includes the Symphony Cartridge, which comes pre-loaded with essential reagents and components. The company additionally provides the ALLEREYE diagnostic test, a convenient, on-site device for quickly identifying allergic conjunctivitis. Bluejay Diagnostics is also progressing with the development of Symphony IL-6 tests, intended for monitoring disease advancement in critical care environments. Furthermore, they are actively creating additional diagnostic tests for their Symphony platform, such as those aimed at detecting myocardial infarction (heart attack) and congestive heart failure. Bluejay Diagnostics, Inc. was founded in 2015 and is headquartered in Acton, Massachusetts.

Valuation in context

P/E ratio
-0.3
N/A
Not meaningful — company is unprofitable
P/B ratio
0.5
Below average
Below the 10-year average
FCF Yield
-332.1%
Below average
Below the 10-year average
Free · No credit card needed

Get alerted when BJDX is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.